Thought Leader LiaisonKyowa Kirin
Disclosure information not submitted.
Understanding CRYSVITA® (burosumab-twza), an FGF23Targeted Therapy sponsored by Kyowa Kirin
Friday, February 21, 20259:00 AM – 9:45 AM East Coast USA Time